Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Home-based Urinary Pregnanediol 3-glucuronide (PDG) Test to Confirm Ovulation

NCT03230084 is registered in ClinicalTrials.gov with Bruyère Health Research Institute. as lead sponsor.

NCT NCT03230084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Home-based Urinary Pregnanediol 3-glucuronide (PDG) Test to Confirm Ovulation
Lead sponsor
Bruyère Health Research Institute.
Phase
Not applicable
Overall status
Completed
Start date
August 23, 2017
Completion date
March 14, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female